Borrelia: Difference between revisions
Shanshan Cen (talk | contribs) |
Shanshan Cen (talk | contribs) |
||
Line 77: | Line 77: | ||
:::* Pediatric regimen (1): (children <8 years of age) [[Amoxicillin]] 50 mg/kg per day in 3 divided doses [maximum of 500 mg per dose] {{or}} [[Cefuroxime axetil]] 30 mg/kg per day in 2 divided doses (maximum of 500 mg per dose) | :::* Pediatric regimen (1): (children <8 years of age) [[Amoxicillin]] 50 mg/kg per day in 3 divided doses [maximum of 500 mg per dose] {{or}} [[Cefuroxime axetil]] 30 mg/kg per day in 2 divided doses (maximum of 500 mg per dose) | ||
:::* Pediatric regimen (2):(children ≥8 years of age)[[Doxycycline]] 4 mg/kg per day in 2 divided doses(maximum of 100 mg per dose) | :::* Pediatric regimen (2):(children ≥8 years of age)[[Doxycycline]] 4 mg/kg per day in 2 divided doses(maximum of 100 mg per dose) | ||
:::* Pediatric regimen (3): [[Azithromycin]] 10 mg/kg per day (maximum of 500 mg per day) {{or}} [[Clarithromycin]] 7.5 mg/kg twice per day (maximum of 500 mg per dose) {{or}} [[Erythromycin]] 12.5 mg/kg 4 times per day (maximum of 500 mg per dose) | |||
::* When erythema migrans cannot be reliably distinguished from community-acquired bacterial cellulitis | ::* When erythema migrans cannot be reliably distinguished from community-acquired bacterial cellulitis | ||
:::* Preferred regimen: [[Amoxicillin]]–clavulanic acid 500 mg 3 times per day; | :::* Preferred regimen: [[Amoxicillin]]–clavulanic acid 500 mg 3 times per day; | ||
:::* Pediatric regimen;[[Amoxicillin]]–clavulanic acid 50 mg/kg per day in 3 divided doses (maximum of 500 mg per dose) | :::* Pediatric regimen;[[Amoxicillin]]–clavulanic acid 50 mg/kg per day in 3 divided doses (maximum of 500 mg per dose) | ||
::* Lyme meningitis and other manifestations of early neurologic Lyme disease | ::* Lyme meningitis and other manifestations of early neurologic Lyme disease | ||
:::* Preferred regimen: [[Ceftriaxone]] 2g once per day IV for 10–28 days | :::* Preferred regimen: [[Ceftriaxone]] 2g once per day IV for 10–28 days | ||
Line 92: | Line 93: | ||
::* Lyme carditis | ::* Lyme carditis | ||
:::* Preferred regimen: | :::* Preferred regimen: [[Ceftriaxone]] 2g once per day IV for 10–28 days | ||
:::* NOTE: patients with advanced heart block, a temporary pacemaker may be required; expert consultation with a cardiologist is recommended; Use of the pacemaker may be discontinued when the advanced heart block has resolved; An oral antibiotic treatment regimen should be used for completion of therapy and for outpatients, as is used for patients with erythema migrans without carditis (see above) | |||
::* Borrelial lymphocytoma | ::* Borrelial lymphocytoma | ||
:::* Preferred regimen: | :::* Preferred regimen: The same regimens used to treat patients with erythema migrans (see above) | ||
Revision as of 15:43, 25 June 2015
Borrelia | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Scientific classification | ||||||||||||
| ||||||||||||
Species | ||||||||||||
Borrelia afzelii |
Template:Seealso Template:Seealso
WikiDoc Resources for Borrelia |
Articles |
---|
Most recent articles on Borrelia |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Borrelia at Clinical Trials.gov Clinical Trials on Borrelia at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Borrelia
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Directions to Hospitals Treating Borrelia Risk calculators and risk factors for Borrelia
|
Healthcare Provider Resources |
Causes & Risk Factors for Borrelia |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Borrelia is a genus of bacteria of the spirochete class. It is a zoonotic, vector-borne disease transmitted primarily by ticks and some by lice, depending on the species. There are 37 known species of Borrelia.
Borreliosis (Lyme disease)
Of the 37 known species of Borrelia, 12 of these species are known to cause Lyme disease or borreliosis and are transmitted by ticks. The major Borrelia species causing Lyme disease are Borrelia burgdorferi, Borrelia afzelii, Borrelia garinii and Borrelia valaisiana.
Relapsing fever
Other Borrelia species cause relapsing fever such as Borrelia recurrentis, caused by the human body louse. No animal reservoir of B. recurrentis exists. Lice that feed on infected humans acquire the Borrelia organisms that then multiply in the gut of the louse. When an infected louse feeds on an uninfected human, the organism gains access when the victim crushes the louse or scratches the area where the louse is feeding. B. recurrentis infects the person via mucous membranes and then invades the bloodstream.
Other tick-borne relapsing infections are acquired from other species, such as Borrelia hermsii or Borrelia Parkeri, which can be spread from rodents, and serve as a reservoir for the infection, via a tick vector. Borelia hermsii and Borrelia recurrentis cause very similar diseases although the disease associated with Borrelia hermsii has more relapses and is responsible for more fatalities, while the disease caused by B. recurrentis has longer febrile and afebrile intervals and a longer incubation period.
Gallery
-
"Black-legged ticks", Ixodes scapularis, also referred to as I. dammini, are found on a wide rage of hosts. From Public Health Image Library (PHIL). [1]
-
Female “Lone star tick” From Public Health Image Library (PHIL). [1]
-
Dorsal view of the “soft tick” Carios kelleyi. From Public Health Image Library (PHIL). [1]
-
Dorsal view of the “soft tick” Carios kelleyi. From Public Health Image Library (PHIL). [1]
-
White tail deer during a Lyme disease field investigation. From Public Health Image Library (PHIL). [1]
-
White-footed mouse, Peromyscus leucopus, which is a host of ticks thatare known to carry the bacteria, Borrelia burgdorferi, responsible for Lyme disease. From Public Health Image Library (PHIL). [1]
Treatment
Antimicrobial Regimen
- Tick-Borne Relapsing Fever [2]
- Preferred regimen: Doxycycline 100 mg PO twice daily for 5-10 days
- Alternative regimen: Erythromycin 500 mg PO four times a day for 5-10 days
- NOTE: If meningitis/encephalitis present, use Ceftriaxone 2 g IV q12h for 14 days
- Louse-Borne Relapsing Fever
- Preferred regimen: single dose Tetracycline 500 mg PO
- Alternative regimen: single dose Erythromycin 500 mg PO
- Lyme disease
- Early Lyme Disease
- Erythema migrans
- Preferred regimen: Doxycycline 100 mg twice per day for 10-21 days OR Amoxicillin 500 mg 3 times per day for 14-21 days OR Cefuroxime axetil 500 mg twice per day for 14-21 days
- Alternatie regimen: : Azithromycin 500 mg PO per day for 7–10 days OR Clarithromycin 500 mg PO twice per day for 14–21 days (if the patient is not pregnant) OR Erythromycin 500 mg PO 4 times per day for 14–21 days
- Pediatric regimen (1): (children <8 years of age) Amoxicillin 50 mg/kg per day in 3 divided doses [maximum of 500 mg per dose] OR Cefuroxime axetil 30 mg/kg per day in 2 divided doses (maximum of 500 mg per dose)
- Pediatric regimen (2):(children ≥8 years of age)Doxycycline 4 mg/kg per day in 2 divided doses(maximum of 100 mg per dose)
- Pediatric regimen (3): Azithromycin 10 mg/kg per day (maximum of 500 mg per day) OR Clarithromycin 7.5 mg/kg twice per day (maximum of 500 mg per dose) OR Erythromycin 12.5 mg/kg 4 times per day (maximum of 500 mg per dose)
- When erythema migrans cannot be reliably distinguished from community-acquired bacterial cellulitis
- Preferred regimen: Amoxicillin–clavulanic acid 500 mg 3 times per day;
- Pediatric regimen;Amoxicillin–clavulanic acid 50 mg/kg per day in 3 divided doses (maximum of 500 mg per dose)
- Lyme meningitis and other manifestations of early neurologic Lyme disease
- Preferred regimen: Ceftriaxone 2g once per day IV for 10–28 days
- Alternative regimen (1): Cefotaxime 2 g IV q8h OR Penicillin G 18–24 million U q4h per day for patients with normal renal function
- Alternative regimen (2): Doxycycline 200–400 mg per day in 2 divided doses PO for 10–28 days
- Pediatric regimen (1): Ceftriaxone 50–75 mg/kg per day in a single daily intravenous dose (maximum, 2g)
- Pediatric regimen (2): Cefotaxime 150–200 mg/kg per day divided into 3 or 4 intravenous doses per day (maximum, 6 g per day)
- Pediatric regimen (3): Penicillin G 200,000–400,000 units/kg per day (maximum, 18–24 million U per day) divided into doses given intravenously q4h for those with normal renal function
- Pediatric regimen (4): (≥8 years old) Doxycycline 4–8 mg/kg PO per day in 2 divided doses (maximum, 100–200 mg per dose)
- Lyme carditis
- Preferred regimen: Ceftriaxone 2g once per day IV for 10–28 days
- NOTE: patients with advanced heart block, a temporary pacemaker may be required; expert consultation with a cardiologist is recommended; Use of the pacemaker may be discontinued when the advanced heart block has resolved; An oral antibiotic treatment regimen should be used for completion of therapy and for outpatients, as is used for patients with erythema migrans without carditis (see above)
- Borrelial lymphocytoma
- Preferred regimen: The same regimens used to treat patients with erythema migrans (see above)
- Late Lyme Disease
- Lyme arthritis
- Preferred regimen:
- Late neurologic Lyme disease
- Preferred regimen:
- Acrodermatitis chronica atrophicans
- Preferred regimen:
- Coinfection
- Preferred regimen:
- Post–Lyme Disease Syndromes
- Preferred regimen:
External links
References
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 "Public Health Image Library (PHIL)".
- ↑ Bartlett, John (2012). Johns Hopkins ABX guide : diagnosis and treatment of infectious diseases. Burlington, MA: Jones and Bartlett Learning. ISBN 978-1449625580.